SCHEMBL2394634

SCHEMBL2394634

COC(=O)c1ccc(C(=O)Nc2cc3c4c(c2)CCCCC4CCCC3)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
KDM4E B2RXH2 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
P4HTM Q9NXG6 1/20 0.42
ROCK2 O75116 1/20 0.41
ALDH1A1 P00352 3/20 0.40
POLB P06746 1/20 0.40
LMNA P02545 1/20 0.40
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2394759 0.97 MAPK1 (0.49) MAPK1KDM4EL3MBTL1RAB9ASMN1; SMN2
SCHEMBL2392565 0.89 MAPK1 (0.48) MAPK1KDM4ERAB9ASMN1; SMN2MAPT
SCHEMBL2391520 0.88 RAB9A (0.45) KDM4EL3MBTL1RAB9ASMN1; SMN2MAPT
SCHEMBL2393106 0.86 ALDH1A1 (0.48) MAPK1KDM4ERAB9ASMN1; SMN2MAPT
SCHEMBL2396462 0.84 RAB9A (0.46) KDM4EL3MBTL1RAB9ASMN1; SMN2MAPT
SCHEMBL2396701 0.83 ALDH1A1 (0.49) MAPK1KDM4ERAB9ASMN1; SMN2MAPT
SCHEMBL2392793 0.83 DEGS1 (0.50) RAB9ANPC1TP53MEN1KMT2A
SCHEMBL2393099 0.81 P4HTM (0.55) KDM4EL3MBTL1RAB9ASMN1; SMN2MAPT
SCHEMBL2393644 0.81 NPC1 (0.50) MAPK1RAB9ASMN1; SMN2MAPTNPC1
SCHEMBL2392818 0.80 MAPK1 (0.48) MAPK1KDM4EL3MBTL1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2189443-B1 TRICYCLIC AMIDE COMPOUND RES FOUND ITSUU LAB (JP) 2013-10-23 EP disclosed
US-8232300-B2 Tricyclic amide compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-07-31 US disclosed
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
EP-2189443-A1 TRICYCLIC AMIDE COMPOUND Research Foundation Itsuu Laboratory (JP) 2010-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RXRA, RXRB, RXRG MAPK1 3796/4885KDM4E 3386/4885L3MBTL1 4033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.